Literature DB >> 8621748

Influence of glucose supply and demand on determination of brain glucose content with labeled methylglucose.

H Nakanishi1, N F Cruz, K Adachi, L Sokoloff, G A Dienel.   

Abstract

The equilibrium brain/plasma distribution ratio for 3-0-methyl-D-glucose (methylglucose) varies with plasma and tissue glucose contents and can be used to determine local glucose levels in brain. This ratio was previously found to rise as brain glucose concentration fell in response to lowered plasma glucose content. The ratios, however, differed with the same tissue glucose levels in conscious and pentobarbital-sedated rats, suggesting that changes in metabolic demand might alter the quantitative relationship between the methylglucose distribution ratio and brain glucose concentration. To examine this possibility, metabolic rate was varied by focal drug application, and hexose concentrations measured in treated and surrounding tissue. When tissue glucose levels were reduced by raised metabolic demand, methylglucose distribution ratios also fell. When brain glucose levels rose due to reduced consumption, the methylglucose distribution ratio also rose. Thus, in contrast to the inverse relationship between brain/plasma methylglucose ratio and brain glucose concentration when brain glucose content is altered secondarily to changes in plasma glucose level, changes in brain glucose content induced by altered glucose utilization cause the brain glucose level and methylglucose distribution ratio to rise and fall in a direct relationship. Determination of brain glucose content from methylglucose distribution ratios must take into account rates of glucose delivery and consumption.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8621748     DOI: 10.1097/00004647-199605000-00010

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  14 in total

Review 1.  Metabolic neuroimaging of the brain in diabetes mellitus and hypoglycaemia.

Authors:  Yee-Seun Cheah; Stephanie A Amiel
Journal:  Nat Rev Endocrinol       Date:  2012-06-26       Impact factor: 43.330

2.  Microdialysate concentration changes do not provide sufficient information to evaluate metabolic effects of lactate supplementation in brain-injured patients.

Authors:  Gerald A Dienel; Douglas L Rothman; Carl-Henrik Nordström
Journal:  J Cereb Blood Flow Metab       Date:  2016-09-07       Impact factor: 6.200

3.  Differential changes in brain glucose metabolism during hypoglycaemia accompany loss of hypoglycaemia awareness in men with type 1 diabetes mellitus. An [11C]-3-O-methyl-D-glucose PET study.

Authors:  E M Bingham; J T Dunn; D Smith; J Sutcliffe-Goulden; L J Reed; P K Marsden; S A Amiel
Journal:  Diabetologia       Date:  2005-09-06       Impact factor: 10.122

4.  Determination of Glucose Utilization Rates in Cultured Astrocytes and Neurons with [14C]deoxyglucose: Progress, Pitfalls, and Discovery of Intracellular Glucose Compartmentation.

Authors:  Gerald A Dienel; Nancy F Cruz; Louis Sokoloff; Bernard F Driscoll
Journal:  Neurochem Res       Date:  2015-07-04       Impact factor: 3.996

Review 5.  Molecular imaging of tumors by chemical exchange saturation transfer MRI of glucose analogs.

Authors:  Michal Rivlin; Gil Navon
Journal:  Quant Imaging Med Surg       Date:  2019-10

6.  Metabolomic Assays of Postmortem Brain Extracts: Pitfalls in Extrapolation of Concentrations of Glucose and Amino Acids to Metabolic Dysregulation In Vivo in Neurological Diseases.

Authors:  Gerald A Dienel
Journal:  Neurochem Res       Date:  2018-08-16       Impact factor: 3.996

7.  Uptake of 18F-labeled 6-fluoro-6-deoxy-D-glucose by skeletal muscle is responsive to insulin stimulation.

Authors:  Chandra Spring-Robinson; Visvanathan Chandramouli; William C Schumann; Peter F Faulhaber; Yanming Wang; Chunying Wu; Faramarz Ismail-Beigi; Raymond F Muzic
Journal:  J Nucl Med       Date:  2009-05-14       Impact factor: 10.057

8.  Glucose metabolism down-regulates the uptake of 6-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose (6-NBDG) mediated by glucose transporter 1 isoform (GLUT1): theory and simulations using the symmetric four-state carrier model.

Authors:  Mauro DiNuzzo; Federico Giove; Bruno Maraviglia; Silvia Mangia
Journal:  J Neurochem       Date:  2013-02-27       Impact factor: 5.372

9.  The rate-limiting step for glucose transport into the hypothalamus is across the blood-hypothalamus interface.

Authors:  Carol Poitry-Yamate; HongXia Lei; Rolf Gruetter
Journal:  J Neurochem       Date:  2009-05       Impact factor: 5.372

Review 10.  Lactate shuttling and lactate use as fuel after traumatic brain injury: metabolic considerations.

Authors:  Gerald A Dienel
Journal:  J Cereb Blood Flow Metab       Date:  2014-09-10       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.